← Evidence map

ArticleClinicoEconomics and outcomes research : CEOR2022

Budget Impact Analysis of Mepolizumab for Eligible Patients in the Setting of a Severe Asthma Clinic Within Dubai Health Authority (DHA).

Bassam Mahboub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35502155